Symbio Generrics is a specialized API manufacturing, marketing, and CDMO organization headquartered in Bengaluru, India. Founded by industry veterans from Biocon, the company has grown rapidly into a fully integrated API player with robust R&D and manufacturing facilities. Its core focus is on supplying high-quality APIs and intermediates to both emerging and regulated pharmaceutical markets globally. The company also offers Contract Development & Manufacturing (CDMO) services for custom APIs and intermediates with regulatory compliance capabilities.Company CEO / Managing Director Akash Suresh Puranik – Promoter, Managing Director & CEO Salim Shaikh – Founder & Executive ChairmanIndustry Pharmaceuticals – Active Pharmaceutical Ingredients (APIs), Intermediates, and Contract Development & Manufacturing Organization (CDMO) servicesOwnership Type Privately held, backed by equity investment from Ascent Capital, with 100% promoter ownershipCompany Details / Key Capabilities
Vertically integrated API services: manufacturing facilities in Dobbaspet (Bengaluru) and Achutapuram (Visakhapatnam)
R&D center located in Jigani, Bengaluru, developing new intermediates & APIs for regulated markets
Global marketing alliances with pharma formulation partners across regulated and emerging markets
Focus on growth via strategic acquisitions and obtaining global regulatory approvals such as US FDALocation / Headquarters Corporate address: Symbio House, 24th Main, 11th Cross, HSR Layout, Bengaluru, Karnataka, India Manufacturing sites in Bengaluru (Dobbaspet) and Vizag/Achutapuram; R&D center in Jigani, Bengaluru
Website www.symbiogenerics.comNumber of Employees Approximately 160–170, including ~15 dedicated scientists. Data as of April 2024Established In Incorporated in May 2011 (official incorporation date: 30 May 2011); operations began around 2010 with founders from Biocon
